Evidence review finds link between paracetamol and autism to be low

An in-depth evidence review published in the British Medical Journal has concluded that there is no clear link between taking paracetamol in pregnancy and the chances of a child having autism or attention deficit/hyperactivity disorder (ADHD) later in life.

The review found that the quality of existing studies supporting such a link was “low to critically low,” suggesting that any apparent effect can likely be attributed to family genetics and other factors.

Research was drawn from nine systematic reviews covering 40 studies, and it was fast-tracked for publication after remarks made by US President Donald Trump in September when he advised women against taking the pain reliever during pregnancy.

Importance of getting the truth about autism out there

Mel Merritt, Head of Policy and Campaigns at the National Autistic Society, said: “We’re glad this review has been fast-tracked, highlighting the urgency and importance of getting the truth out there – that taking paracetamol in pregnancy does not cause autism. Sadly, this research won’t get a fraction of the attention that false claims do. But the truth matters. It’s important that everyone understands the real facts and seeks out safe and reliable information.

“The reason this is factual and accurate information is that this is a systematic review of research studies about paracetamol and autism/ ADHD – this is a robust way of looking at the research that already exists.

“Following the recent attention false claims about autism got, autistic people and their families told us they felt judged. Spreading misinformation, focusing on ‘cures’ and causes only perpetuates stigma for autistic people, who already fight every day for a diagnosis, school support, access to healthcare and mental health and employment support. It’s time to focus on bringing about the real change autistic people need and deserve.”

Alison Bloomer

Alison Bloomer is Editor of Learning Disability Today.

See Full Bio